4-Chloro-3-nitroanisole

We are 4-Chloro-3-nitroanisole CAS:10298-80-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Chloro-3-nitroanisole
CAS.NO:10298-80-3
Synonyms:4-Chloro-3-nitroanisole
1-chloro-4-methoxy-2-nitrobenzene
2-Nitro-4-methoxychlorobenzene
2-CHLORO-5-METHOXYNITROBENZENE
4-Chlor-3-nitro-anisol
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 293.3±20.0 °C at 760 mmHg
Melting Point 41-43 °C(lit.)
Molecular Formula C7H6ClNO3
Molecular Weight 187.580
Flash Point 131.2±21.8 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.560
 
Specification:
Appearance:Light yellow crystalline powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Iguratimod(CAS:123663-49-0).

4-Chloro-3-nitroanisole


Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.1H-Benzimidazole-2-carboxylic acid This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.DL-Norleucine This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.(3R, 4S) -3-Hidroxi-4-fenilazetidin-2-ona CAS:132127-34-5 Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.

Related Products
Product Name
Difluoroiodomethane Cas:1493-03-4 View Details
2,2-Difluoro-2-(fluorosulfonyl)acetic acid Cas:1717-59-5 View Details
4-Methyl-N3-[4-(3-Pyridinyl)-2-Pyrimidinyl]-1,3-Benzenediamine View Details
2-Hydroxy-5-trifluoromethylpyridine manufacturer 2-Bromovaleric acid manufacturer Propyl Gallate manufacturer Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane manufacturer 2,4-Difluoro-5-nitrobenzonitrile manufacturer